ArticleDiscover oncology2025

A risk signature constructed by Tregs-related genes predict the clinical outcomes and immune therapeutic response in kidney cancer.

Gang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.